Drug intelligence / Profile preview

TheraCal

Development stage
Phase 4
Lead developer
BISCO
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Topical
01

Overview

TheraCal is a resin-modified calcium silicate dental material developed and manufactured by BISCO Inc. It is primarily used in vital pulp therapy, including direct and indirect pulp capping and pulpotomy procedures for teeth affected by dental caries. The material is designed to be moisture-tolerant and radiopaque, facilitating its use as a protective liner and base. Its therapeutic effect is derived from the release of calcium ions and the maintenance of an alkaline pH, which together promote the formation of a reparative dentin bridge and support the healing of the dental pulp. TheraCal is available in two main formulations: TheraCal LC, which is light-cured, and TheraCal PT, which is dual-cured and specifically indicated for pulpotomy.

Brand names
TheraCal LCTheraCal PT
Other names
resin-modified calcium silicate

Beyond the preview

Go deeper on TheraCal.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TheraCal.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call